search button

Proliferation and metastatic potential of endometrial cancer cells in response to metformin treatment in a high versus normal glucose environment

  • Authors:
    • Amanda de Barros Machado
    • Vania dos Reis
    • Sebastian Weber
    • Julia Jauckus
    • Ilma Simoni Brum
    • Helena von Eye Corleta
    • Thomas Strowitzki
    • Edison Capp
    • Ariane Germeyer

  • View Affiliations

  • Published online on: August 23, 2016     https://doi.org/10.3892/ol.2016.5041
  • Pages: 3626-3632
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In order to improve our understanding of the potential preventive and therapeutic role of metformin, the present study aimed to investigate the capability of low‑dose metformin in the efficient inhibition of cancer development and the reduction of the metastasis of endometrial adenocarcinoma type I and primary endometrial epithelial cells (eEPs), with the drug acting as a treatment in a hyperinsulinemic environment exposed to high and normal glucose conditions. The Ishikawa endometrial adenocarcinoma cell line and primary eEPs were exposed to an environment with high (17 mM) or normal glucose (5 mM) and treated with insulin, low‑dose metformin (0.1 mM) or a combined treatment. Metastatic potential was assessed by migration and invasion assays, and relative cell proliferation was determined. Metformin at a low dose potently inhibited the insulin action, decreasing the ability of the endometrial cancer (EC) cell line to migrate and invade in a high and normal glucose environment, and decreasing the migration ability of the primary eEPs. In the EC cell line, the insulin treatment increased the proliferation, without any subsequent reduction of proliferation by the addition of 0.1 mM metformin; however, relative cell proliferation sensitivity to metformin was observed in the range between 1 and 5 mM regardless of the glucose concentration present. Overall, metformin at 0.1 mM is not efficient enough to decrease the proliferation in an EC cell line. However, at this concentration, metformin can inhibit the insulin action in endometrial epithelial cancer cells, demonstrating an anti‑metastatic effect in high and normal glucose environments.
View Figures
View References

Related Articles

Journal Cover

November-2016
Volume 12 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 5.7
  • CiteScore Rank: Q2: #139/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.574
  • SCImago Journal Rank (SJR): 0.644
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
de Barros Machado A, dos Reis V, Weber S, Jauckus J, Brum IS, von Eye Corleta H, Strowitzki T, Capp E and Germeyer A: Proliferation and metastatic potential of endometrial cancer cells in response to metformin treatment in a high versus normal glucose environment. Oncol Lett 12: 3626-3632, 2016.
APA
de Barros Machado, A., dos Reis, V., Weber, S., Jauckus, J., Brum, I.S., von Eye Corleta, H. ... Germeyer, A. (2016). Proliferation and metastatic potential of endometrial cancer cells in response to metformin treatment in a high versus normal glucose environment. Oncology Letters, 12, 3626-3632. https://doi.org/10.3892/ol.2016.5041
MLA
de Barros Machado, A., dos Reis, V., Weber, S., Jauckus, J., Brum, I. S., von Eye Corleta, H., Strowitzki, T., Capp, E., Germeyer, A."Proliferation and metastatic potential of endometrial cancer cells in response to metformin treatment in a high versus normal glucose environment". Oncology Letters 12.5 (2016): 3626-3632.
Chicago
de Barros Machado, A., dos Reis, V., Weber, S., Jauckus, J., Brum, I. S., von Eye Corleta, H., Strowitzki, T., Capp, E., Germeyer, A."Proliferation and metastatic potential of endometrial cancer cells in response to metformin treatment in a high versus normal glucose environment". Oncology Letters 12, no. 5 (2016): 3626-3632. https://doi.org/10.3892/ol.2016.5041